|
|||
| December 31, | |||
| In millions, except per share amounts | 1998 | 1997 | |
|
|||
| Assets: | |||
| Cash and cash equivalents | $180.8 | $192.5 | |
| Accounts receivable, net | 650.3 | 452.4 | |
| Inventories | 3,190.2 | 2,882.4 | |
| Other current assets | 327.9 | 364.8 | |
|
|
|||
| Total current assets |
4,349.2 | 3,892.1 | |
| Property and equipment, net | 1,351.2 | 1,072.3 | |
| Goodwill, net | 724.6 | 711.5 | |
| Deferred charges and other assets | 311.2 | 303.0 | |
|
|
|||
| Total assets | $6,736.2 | $5,978.9 | |
|
|
|||
| Liabilities: | |||
| Accounts payable | $1,286.3 | $1,233.7 | |
| Accrued expenses | 1,111.3 | 1,168.6 | |
| Short-term borrowings | 771.1 | 466.4 | |
| Current maturities of long-term debt | 14.6 | 41.9 | |
|
|
|||
| Total current liabilities |
3,183.3 | 2,910.6 | |
| Long-term debt | 275.7 | 290.4 | |
| Other long-term liabilities |
166.6 | 163.3 | |
|
Commitments and contingencies (Note 14)
Shareholders’ equity: |
|||
|
Preferred stock, $0.01 par value: authorized 120,619 shares,
0 shares issued and outstanding |
— | — | |
|
Preference stock, series one ESOP convertible, par value $1.00:
authorized 50,000,000 shares; issued and outstanding 5,239,000 shares at December 31, 1998 and 5,324,000 shares at December 31, 1997 |
280.0 | 284.6 | |
|
Common stock, par value $0.01: authorized 1,000,000,000 shares;
issued 401,380,000 shares at December 31, 1998 and 393,734,000 shares at December 31, 1997 |
4.0 | 3.9 | |
|
Treasury stock, at cost: 11,169,000 shares at December 31, 1998 and
11,278,000 shares at December 31, 1997 |
(260.2) | (262.9) | |
| Guaranteed ESOP obligation | (270.7) | (292.2) | |
| Capital surplus | 1,336.4 | 1,154.0 | |
| Retained earnings | 2,021.1 | 1,727.2 | |
|
|
|||
| Total shareholders’ equity | 3,110.6 | 2,614.6 | |
|
|
|||
| Total liabilities and shareholders’ equity | $6,736.2 | $5,978.9 | |
|
|
|||
See accompanying notes to consolidated financial statements.
Download this section in PDF format.
|
copyright
©1998 CVS/pharmacy, Inc.
|